Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H36O5 |
Molecular Weight | 344.4861 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O
InChI
InChIKey=HYHMLYSLQUKXKP-UHFFFAOYSA-N
InChI=1S/C19H36O5/c1-18(2,16(21)22)13-9-5-7-11-15(20)12-8-6-10-14-19(3,4)17(23)24/h15,20H,5-14H2,1-4H3,(H,21,22)(H,23,24)
Molecular Formula | C19H36O5 |
Molecular Weight | 344.4861 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:39:04 UTC 2023
by
admin
on
Fri Dec 15 19:39:04 UTC 2023
|
Record UNII |
1EJ6Z6Q368
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
812621
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1EJ6Z6Q368
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
10472693
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
DTXSID401027952
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL3545313
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
1EJ6Z6Q368
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
100000169469
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
SUB183128
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
149601
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
B-131
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
C166494
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
DB11936
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
Bempedoic Acid
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
5382
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
738606-46-7
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
9891
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
2282403
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY | |||
|
Bempedoic acid
Created by
admin on Fri Dec 15 19:39:04 UTC 2023 , Edited by admin on Fri Dec 15 19:39:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
FECAL; URINE
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
Ki
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
AT STEADY-STATE |
|||
Tmax | PHARMACOKINETIC |
|
|
|||